Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- 1st Generation Poultices “Just One Example” for Proposal to Scrap Health Coverage for OTC-Like Drugs: Shirakawa
March 26, 2015
- Applying Uniform Pricing Rule to Unprofitable but Essential Drugs Difficult: Kenporen Veep
March 26, 2015
- JPMA to Begin Operating New Statistical Drug Database in FY2015
March 23, 2015
- JPMA Suspends Hasegawa’s Veep Duties for Another 2 Months over CASE-J
March 20, 2015
- FPMAJ Renews Call for Changing NHI Pricing Rules for Unprofitable Drugs with Great Medical Needs
March 20, 2015
- JPWA Calls on MHLW to Narrow Down Range of Pharmacies Subjected to Medical Fee Cut Rule for Low Price Settlement Rates
March 20, 2015
- Kyokai Kenpo Aims to Increase Generic Usage Rate to 65.1%
March 20, 2015
- JHSF Calls for Tax Incentives to Promote Investment in Regenerative Medicine
March 19, 2015
- Majority of Doctors Dissatisfied with Existing Treatments for AD, Pancreatic Cancer: JHSF
March 18, 2015
- Bone-Forming Agents Most Needed for Osteoporosis in 2025: JHSF Survey
March 18, 2015
- JSGM President Calls for Generic Share Target of 80% by FY2020
March 12, 2015
- Medwatcher Accuses HPV Vaccine Makers of Violating JPMA’s Promotion Code
March 2, 2015
- JPMA to Inform Medical Institutions of New R&D Cost Disclosure Plan in April
February 20, 2015
- AJMC Announces Guidelines for Investigator-Led Clinical Trials
February 20, 2015
- PhRMA Sets to Make Direct Plea to Finance Minister to Drop Annual Price Cut Plan
February 6, 2015
- Number of Contract Sales Reps Increased to 4,148 as of Oct. 2014: CSO Association
February 4, 2015
- JPWA President Reiterates Opposition to Annual NHI Price Revisions
February 2, 2015
- IMI, WADA Sign MOU to Prevent Use of Experimental Drugs for Doping
January 30, 2015
- July-Sept. Generic Share Reaches 51.3% under New Formula: JGA
January 30, 2015
- JPMA Draft Guidelines Urge Companies to Separate Ad Reviewing Bodies from Sales Units
January 27, 2015
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…